Phase 2b RewinD-LB trial of neflamapimod for the treatment of dementia with Lewy Bodies (DLB) is fully enrolled with topline…
The Abliva team invites you to a conference call to discuss the positive outcome of the interim analysis for FALCON,…
Join Aligos Therapeutics for a virtual KOL event featuring Mark Sulkowski, MD (Johns Hopkins University School of Medicine), who will…
Join Biora Therapeutics for a virtual KOL event featuring Bruce Sands, MD, MS (Icahn School of Medicine at Mount Sinai) and Brian Feagan,…
Join Arrowhead Pharmaceuticals for Part III of its 2024 Summer Series of R&D Webinars, featuring Matthias A. Salathe, MD (University of…
Join Purple Biotech for a virtual key opinion leader (KOL) event featuring Michael Cecchini, MD (Yale School of Medicine) and E. Gabriela Chiorean,…
Join IDEAYA Biosciences for an investor webcast to provide a clinical data update for the IDE397 Phase 2 monotherapy expansion…

Nusano and LifeSci Advisors invite you to go back to school . . . Join us on Friday, June 28,…
Join R1 RCM, a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems,…
Join X4 Pharmaceuticals for a virtual investor event featuring Peter E. Newburger, MD (UMass Chan Medical School) and Jean Donadieu, MD, PhD (Trousseau…
Join FibroGen for the second part of the virtual KOL investor event series featuring Rahul Aggarwal, MD (University of California San Francisco),…
Join Protalix Biotherapeutics for an in-person investor day in New York featuring presentations by the following key opinion leaders: Aleš Linhart, DSc,…
Join Arrowhead Pharmaceuticals for Part II of its 2024 Summer Series of R&D Webinars, featuring Christie M. Ballantyne, MD, FACP,…
Join Brainomix for a virtual KOL event featuring Dr. Waleed Brinjikji, M.D. (Mayo Clinic), who will join Brainomix CEO and Co-Founder, Dr. Michalis…
Join Aprea Therapeutics for a virtual event featuring Joseph P. Vacca, PhD, Medical Chemistry Expert and Consultant to Aprea Therapeutics, who…
Join Milestone Pharmaceuticals for Part I of its virtual KOL event series for investors featuring George Mark, MD, FACC* and Vivek Sailam, MD from…